202 related articles for article (PubMed ID: 11346206)
1. Increased serum levels of eotaxin in patients with inflammatory bowel disease.
Chen W; Paulus B; Shu D; Wilson ; Chadwick V
Scand J Gastroenterol; 2001 May; 36(5):515-20. PubMed ID: 11346206
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.
Manousou P; Kolios G; Valatas V; Drygiannakis I; Bourikas L; Pyrovolaki K; Koutroubakis I; Papadaki HA; Kouroumalis E
Clin Exp Immunol; 2010 Nov; 162(2):337-47. PubMed ID: 21077277
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
[TBL] [Abstract][Full Text] [Related]
5. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
[TBL] [Abstract][Full Text] [Related]
6. Intraepithelial lymphocyte eotaxin-2 expression and perineural mast cell degranulation differentiate allergic/eosinophilic colitis from classic IBD.
Torrente F; Barabino A; Bellini T; Murch SH
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):300-7. PubMed ID: 24813533
[TBL] [Abstract][Full Text] [Related]
7. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
Griga T; Gutzeit A; Sommerkamp C; May B
Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):175-9. PubMed ID: 10102229
[TBL] [Abstract][Full Text] [Related]
8. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique.
Jeziorska M; Haboubi N; Schofield P; Woolley DE
J Pathol; 2001 Aug; 194(4):484-92. PubMed ID: 11523058
[TBL] [Abstract][Full Text] [Related]
9. B cells secrete eotaxin-1 in human inflammatory bowel disease.
Rehman MQ; Beal D; Liang Y; Noronha A; Winter H; Farraye FA; Ganley-Leal L
Inflamm Bowel Dis; 2013 Apr; 19(5):922-33. PubMed ID: 23511032
[TBL] [Abstract][Full Text] [Related]
10. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
[TBL] [Abstract][Full Text] [Related]
11. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis.
Kagami S; Kakinuma T; Saeki H; Tsunemi Y; Fujita H; Nakamura K; Takekoshi T; Kishimoto M; Mitsui H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792
[TBL] [Abstract][Full Text] [Related]
12. High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis.
Coburn LA; Horst SN; Chaturvedi R; Brown CT; Allaman MM; Scull BP; Singh K; Piazuelo MB; Chitnavis MV; Hodges ME; Rosen MJ; Williams CS; Slaughter JC; Beaulieu DB; Schwartz DA; Wilson KT
PLoS One; 2013; 8(12):e82300. PubMed ID: 24367513
[TBL] [Abstract][Full Text] [Related]
13. Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease.
Denis MA; Louis R; Malaise M; Belaiche J; Louis E
Scand J Gastroenterol; 2001 Feb; 36(2):190-5. PubMed ID: 11252412
[TBL] [Abstract][Full Text] [Related]
14. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.
Ahrens R; Waddell A; Seidu L; Blanchard C; Carey R; Forbes E; Lampinen M; Wilson T; Cohen E; Stringer K; Ballard E; Munitz A; Xu H; Lee N; Lee JJ; Rothenberg ME; Denson L; Hogan SP
J Immunol; 2008 Nov; 181(10):7390-9. PubMed ID: 18981162
[TBL] [Abstract][Full Text] [Related]
15. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation.
De Corso E; Baroni S; Battista M; Romanello M; Penitente R; Di Nardo W; Passali GC; Sergi B; Fetoni AR; Bussu F; Zuppi C; Paludetti G
Int Forum Allergy Rhinol; 2014 Aug; 4(8):617-24. PubMed ID: 24989688
[TBL] [Abstract][Full Text] [Related]
16. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood.
Morita A; Shimosako K; Kikuoka S; Taniguchi Y; Kitaura M; Sasakura K; Tamaki M; Tsuji T; Teraoka H; Yoshie O; Nakajima T; Hirai K
J Immunol Methods; 1999 Jun; 226(1-2):159-67. PubMed ID: 10410981
[TBL] [Abstract][Full Text] [Related]
17. [The role of chemokines in nasal polyps].
Caversaccio M; Hartnell A; Calnan D; Jose P; Mackay IS; Uguccioni M; Baggiolini M; Williams TJ; Conroy DM
Schweiz Med Wochenschr; 2000; Suppl 125():92S-95S. PubMed ID: 11141953
[TBL] [Abstract][Full Text] [Related]
18. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease.
Griga T; Tromm A; Spranger J; May B
Scand J Gastroenterol; 1998 May; 33(5):504-8. PubMed ID: 9648990
[TBL] [Abstract][Full Text] [Related]
20. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
Kucharzik T; Stoll R; Lügering N; Domschke W
Clin Exp Immunol; 1995 Jun; 100(3):452-6. PubMed ID: 7774055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
